Preeta Kaur Chugh

Summary

Publications

  1. ncbi Belimumab: targeted therapy for lupus
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    Int J Rheum Dis 16:4-13. 2013
  2. ncbi Recent advances in the pathophysiology and pharmacological treatment of obesity
    P K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    J Clin Pharm Ther 37:525-35. 2012
  3. ncbi Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial
    Preeta Kaur Narula
    Department of Pharmacology, Lady Hardinge Medical College and Associated SSK Hospitals, New Delhi, India
    Schizophr Res 118:218-23. 2010
  4. ncbi Lupus: novel therapies in clinical development
    Preeta Kaur Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110002, India
    Eur J Intern Med 23:212-8. 2012

Collaborators

  • S Sharma
  • Preeta Kaur Narula
  • Neeraj Gupta
  • H S Rehan
  • K E S Unni

Detail Information

Publications4

  1. ncbi Belimumab: targeted therapy for lupus
    Preeta K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    Int J Rheum Dis 16:4-13. 2013
    ..It could enable development of treatment which could halt long-term progression, minimize target organ damage and thus provide a better quality of life for these patients...
  2. ncbi Recent advances in the pathophysiology and pharmacological treatment of obesity
    P K Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India
    J Clin Pharm Ther 37:525-35. 2012
    ..The increasing prevalence of obesity and associated morbidity present unmet medical needs for safe and effective new drug therapies. Our aim is to review the diverse targets and compounds that are in clinical development...
  3. ncbi Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial
    Preeta Kaur Narula
    Department of Pharmacology, Lady Hardinge Medical College and Associated SSK Hospitals, New Delhi, India
    Schizophr Res 118:218-23. 2010
    ..The purpose of this study was to assess the efficacy of topiramate to prevent olanzapine induced WG in these cases. We also studied various metabolic parameters...
  4. ncbi Lupus: novel therapies in clinical development
    Preeta Kaur Chugh
    Department of Pharmacology, Maulana Azad Medical College and Associated Hospitals, Bahadur Shah Zafar Marg, New Delhi 110002, India
    Eur J Intern Med 23:212-8. 2012
    ..This review discusses various drugs which are in different phases of clinical trials and hold promise for patients suffering from this chronic debilitating disease...